ACTRN12607000527460
Completed
未知
A randomised controlled trial of intramuscular droperidol versus intramuscular midazolam for rapid sedation of aggressive and agitated psychostimulant-associated delirium
Geoffrey Isbister0 sites120 target enrollmentOctober 12, 2007
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Psychostimulant induced agitation and delirium
- Sponsor
- Geoffrey Isbister
- Enrollment
- 120
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Emergency department patients with suspected or confirmed severe agitated delirium/psychosis or aggression due to psychostimulant toxicity; AND require intervention by hospital security staff or physical restraint
Exclusion Criteria
- •1\.Patients with acute psychosis clearly due to other causes;
- •2\.Patient who are willing to take oral or intravenous medication for sedation without physical restraint;
- •3\.Patients under the age of 18 years of age;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A randomised controlled trial of intra-muscular Lorazepam versus intra-muscular Haloperidol and Promethazine in the management of psychotic agitations and aggressioISRCTN29863938Christian Medical College and Hospital (India)200
Recruiting
Phase 1
A Randomized Controlled Trial of Intramuscular Gonadotropin-Releasing Hormone (GnRH)-analogue Stimulation Test Compared to Subcutaneous Injection to Diagnose in Girls with Central Precocious Pubertymaximum LH level(tmax) for the diagnosis of CPP girls after GnRH-analogue stimulation testCentral precocious puberty, diagnosis, Intramuscular, GnRH-analogue stimulation testTCTR20240719003Research Affair Faculty of Medicine Chulalonkorn52
Completed
Not Applicable
Injection therapy to muscle injuries in professional football playersISRCTN78125864Cardiff University (UK) - Medical Engineering25
Completed
Phase 1
Study for effects of Masport in adultsGlabellar Facial lines.IRCT201201154536N2Masoondarou Co.12
Not yet recruiting
Phase 2
Clinical Trial on the Use of Cell Therapy in the Treatment of Patients With Amyotrophic Lateral Sclerosis (TCIM-ELAII)2023-506215-17-00Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia100